DICER1 syndrome - Revision history

Michael at 12:49, 24 March 2024

2024-03-24T12:49:32Z

← Older revision		Revision as of 12:49, 24 March 2024
Line 10:		Line 10:
	*[[Embryonal rhabdomyosarcoma]].<ref>{{cite journal \|authors=Apellaniz-Ruiz M, McCluggage WG, Foulkes WD \|title=DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing \|journal=Genes Chromosomes Cancer \|volume=60 \|issue=3 \|pages=217–233 \|date=March 2021 \|pmid=33135284 \|doi=10.1002/gcc.22913 \|url=}}</ref>		*[[Embryonal rhabdomyosarcoma]].<ref>{{cite journal \|authors=Apellaniz-Ruiz M, McCluggage WG, Foulkes WD \|title=DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing \|journal=Genes Chromosomes Cancer \|volume=60 \|issue=3 \|pages=217–233 \|date=March 2021 \|pmid=33135284 \|doi=10.1002/gcc.22913 \|url=}}</ref>
	*Nasal chondromesenchymal hamartoma.		*Nasal chondromesenchymal hamartoma.
	*DICER1-sarcoma.<ref name=pmid35668302>{{cite journal \|authors=Yang K, Wang J, Kanwar N, Villani A, Ajani O, Fleming A, Patil V, Mamatjan Y, Wei Q, Malkin D, Shlien A, Zadeh G, Provias J \|title=A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL \|journal=Brain Tumor Pathol \|volume=39 \|issue=4 \|pages=225–231 \|date=October 2022 \|pmid=35668302 \|doi=10.1007/s10014-022-00437-2 \|url=}}</ref><ref>{{cite journal \|~~vauthors~~=McCluggage WG, Foulkes WD \|title=DICER1-sarcoma: an emerging entity \|journal=Mod Pathol \|volume=34 \|issue=12 \|pages=2096–2097 \|date=December 2021 \|pmid=34642426 \|doi=10.1038/s41379-021-00935-2 \|url=}}</ref>		*DICER1-sarcoma.<ref name=pmid35668302>{{cite journal \|authors=Yang K, Wang J, Kanwar N, Villani A, Ajani O, Fleming A, Patil V, Mamatjan Y, Wei Q, Malkin D, Shlien A, Zadeh G, Provias J \|title=A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL \|journal=Brain Tumor Pathol \|volume=39 \|issue=4 \|pages=225–231 \|date=October 2022 \|pmid=35668302 \|doi=10.1007/s10014-022-00437-2 \|url=}}</ref><ref name=pmid34642426>{{cite journal \|authors=McCluggage WG, Foulkes WD \|title=DICER1-sarcoma: an emerging entity \|journal=Mod Pathol \|volume=34 \|issue=12 \|pages=2096–2097 \|date=December 2021 \|pmid=34642426 \|doi=10.1038/s41379-021-00935-2 \|url=}}</ref>

	==References==		==References==

Michael at 12:48, 24 March 2024

2024-03-24T12:48:35Z

← Older revision		Revision as of 12:48, 24 March 2024
Line 10:		Line 10:
	*[[Embryonal rhabdomyosarcoma]].<ref>{{cite journal \|authors=Apellaniz-Ruiz M, McCluggage WG, Foulkes WD \|title=DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing \|journal=Genes Chromosomes Cancer \|volume=60 \|issue=3 \|pages=217–233 \|date=March 2021 \|pmid=33135284 \|doi=10.1002/gcc.22913 \|url=}}</ref>		*[[Embryonal rhabdomyosarcoma]].<ref>{{cite journal \|authors=Apellaniz-Ruiz M, McCluggage WG, Foulkes WD \|title=DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing \|journal=Genes Chromosomes Cancer \|volume=60 \|issue=3 \|pages=217–233 \|date=March 2021 \|pmid=33135284 \|doi=10.1002/gcc.22913 \|url=}}</ref>
	*Nasal chondromesenchymal hamartoma.		*Nasal chondromesenchymal hamartoma.
	*DICER1-sarcoma.<ref>{{cite journal \|authors=Yang K, Wang J, Kanwar N, Villani A, Ajani O, Fleming A, Patil V, Mamatjan Y, Wei Q, Malkin D, Shlien A, Zadeh G, Provias J \|title=A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL \|journal=Brain Tumor Pathol \|volume=39 \|issue=4 \|pages=225–231 \|date=October 2022 \|pmid=35668302 \|doi=10.1007/s10014-022-00437-2 \|url=}}</ref><ref>{{cite journal \|vauthors=McCluggage WG, Foulkes WD \|title=DICER1-sarcoma: an emerging entity \|journal=Mod Pathol \|volume=34 \|issue=12 \|pages=2096–2097 \|date=December 2021 \|pmid=34642426 \|doi=10.1038/s41379-021-00935-2 \|url=}}</ref>		*DICER1-sarcoma.<ref name=pmid35668302>{{cite journal \|authors=Yang K, Wang J, Kanwar N, Villani A, Ajani O, Fleming A, Patil V, Mamatjan Y, Wei Q, Malkin D, Shlien A, Zadeh G, Provias J \|title=A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL \|journal=Brain Tumor Pathol \|volume=39 \|issue=4 \|pages=225–231 \|date=October 2022 \|pmid=35668302 \|doi=10.1007/s10014-022-00437-2 \|url=}}</ref><ref>{{cite journal \|vauthors=McCluggage WG, Foulkes WD \|title=DICER1-sarcoma: an emerging entity \|journal=Mod Pathol \|volume=34 \|issue=12 \|pages=2096–2097 \|date=December 2021 \|pmid=34642426 \|doi=10.1038/s41379-021-00935-2 \|url=}}</ref>

	==References==		==References==

Michael at 12:47, 24 March 2024

2024-03-24T12:47:51Z

← Older revision		Revision as of 12:47, 24 March 2024
Line 9:		Line 9:
	Others:		Others:
	*[[Embryonal rhabdomyosarcoma]].<ref>{{cite journal \|authors=Apellaniz-Ruiz M, McCluggage WG, Foulkes WD \|title=DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing \|journal=Genes Chromosomes Cancer \|volume=60 \|issue=3 \|pages=217–233 \|date=March 2021 \|pmid=33135284 \|doi=10.1002/gcc.22913 \|url=}}</ref>		*[[Embryonal rhabdomyosarcoma]].<ref>{{cite journal \|authors=Apellaniz-Ruiz M, McCluggage WG, Foulkes WD \|title=DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing \|journal=Genes Chromosomes Cancer \|volume=60 \|issue=3 \|pages=217–233 \|date=March 2021 \|pmid=33135284 \|doi=10.1002/gcc.22913 \|url=}}</ref>
			*Nasal chondromesenchymal hamartoma.
			*DICER1-sarcoma.<ref>{{cite journal \|authors=Yang K, Wang J, Kanwar N, Villani A, Ajani O, Fleming A, Patil V, Mamatjan Y, Wei Q, Malkin D, Shlien A, Zadeh G, Provias J \|title=A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL \|journal=Brain Tumor Pathol \|volume=39 \|issue=4 \|pages=225–231 \|date=October 2022 \|pmid=35668302 \|doi=10.1007/s10014-022-00437-2 \|url=}}</ref><ref>{{cite journal \|vauthors=McCluggage WG, Foulkes WD \|title=DICER1-sarcoma: an emerging entity \|journal=Mod Pathol \|volume=34 \|issue=12 \|pages=2096–2097 \|date=December 2021 \|pmid=34642426 \|doi=10.1038/s41379-021-00935-2 \|url=}}</ref>

	==References==		==References==
	{{Reflist\|1}}		{{Reflist\|1}}

	[[Category:Syndromes]]		[[Category:Syndromes]]

Michael: +RMS

2024-03-24T12:33:23Z

+RMS

← Older revision		Revision as of 12:33, 24 March 2024
Line 7:		Line 7:
	*[[Cystic nephroma, pediatric type]].<ref name=pmid26772403>{{cite journal \|authors=Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ \|title=Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations \|journal=Hum Pathol \|volume=48 \|issue= \|pages=81–7 \|date=February 2016 \|pmid=26772403 \|pmc=4979561 \|doi=10.1016/j.humpath.2015.08.022 \|url=}}</ref><ref name=pmid28222777>{{cite journal \|authors=Fernández-Martínez L, Villegas JA, Santamaría Í, Pitiot AS, Alvarado MG, Fernández S, Torres H, Paredes Á, Blay P, Balbín M \|title=Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree \|journal=BMC Cancer \|volume=17 \|issue=1 \|pages=146 \|date=February 2017 \|pmid=28222777 \|pmc=5320664 \|doi=10.1186/s12885-017-3136-5 \|url=}}</ref>		*[[Cystic nephroma, pediatric type]].<ref name=pmid26772403>{{cite journal \|authors=Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ \|title=Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations \|journal=Hum Pathol \|volume=48 \|issue= \|pages=81–7 \|date=February 2016 \|pmid=26772403 \|pmc=4979561 \|doi=10.1016/j.humpath.2015.08.022 \|url=}}</ref><ref name=pmid28222777>{{cite journal \|authors=Fernández-Martínez L, Villegas JA, Santamaría Í, Pitiot AS, Alvarado MG, Fernández S, Torres H, Paredes Á, Blay P, Balbín M \|title=Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree \|journal=BMC Cancer \|volume=17 \|issue=1 \|pages=146 \|date=February 2017 \|pmid=28222777 \|pmc=5320664 \|doi=10.1186/s12885-017-3136-5 \|url=}}</ref>

			Others:
			*[[Embryonal rhabdomyosarcoma]].<ref>{{cite journal \|authors=Apellaniz-Ruiz M, McCluggage WG, Foulkes WD \|title=DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing \|journal=Genes Chromosomes Cancer \|volume=60 \|issue=3 \|pages=217–233 \|date=March 2021 \|pmid=33135284 \|doi=10.1002/gcc.22913 \|url=}}</ref>
	==References==		==References==
	{{Reflist\|1}}		{{Reflist\|1}}

	[[Category:Syndromes]]		[[Category:Syndromes]]

Michael at 15:43, 10 March 2022

2022-03-10T15:43:09Z

← Older revision		Revision as of 15:43, 10 March 2022
Line 5:		Line 5:
	*[[Pineoblastoma]].<ref name=pmid28960912/>		*[[Pineoblastoma]].<ref name=pmid28960912/>
	*Ovarian [[Sertoli-Leydig cell tumour]].<ref name=pmid28474256>{{Cite journal \| last1 = Bueno \| first1 = MT. \| last2 = Martínez-Ríos \| first2 = C. \| last3 = la Puente Gregorio \| first3 = A. \| last4 = Ahyad \| first4 = RA. \| last5 = Villani \| first5 = A. \| last6 = Druker \| first6 = H. \| last7 = van Engelen \| first7 = K. \| last8 = Gallinger \| first8 = B. \| last9 = Aronoff \| first9 = L. \| title = Pediatric imaging in DICER1 syndrome. \| journal = Pediatr Radiol \| volume = 47 \| issue = 10 \| pages = 1292-1301 \| month = Sep \| year = 2017 \| doi = 10.1007/s00247-017-3875-0 \| PMID = 28474256 }}</ref><ref name=pmid28654427>{{Cite journal \| last1 = de Kock \| first1 = L. \| last2 = Terzic \| first2 = T. \| last3 = McCluggage \| first3 = WG. \| last4 = Stewart \| first4 = CJR. \| last5 = Shaw \| first5 = P. \| last6 = Foulkes \| first6 = WD. \| last7 = Clarke \| first7 = BA. \| title = DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. \| journal = Am J Surg Pathol \| volume = 41 \| issue = 9 \| pages = 1178-1187 \| month = Sep \| year = 2017 \| doi = 10.1097/PAS.0000000000000895 \| PMID = 28654427 }}</ref>		*Ovarian [[Sertoli-Leydig cell tumour]].<ref name=pmid28474256>{{Cite journal \| last1 = Bueno \| first1 = MT. \| last2 = Martínez-Ríos \| first2 = C. \| last3 = la Puente Gregorio \| first3 = A. \| last4 = Ahyad \| first4 = RA. \| last5 = Villani \| first5 = A. \| last6 = Druker \| first6 = H. \| last7 = van Engelen \| first7 = K. \| last8 = Gallinger \| first8 = B. \| last9 = Aronoff \| first9 = L. \| title = Pediatric imaging in DICER1 syndrome. \| journal = Pediatr Radiol \| volume = 47 \| issue = 10 \| pages = 1292-1301 \| month = Sep \| year = 2017 \| doi = 10.1007/s00247-017-3875-0 \| PMID = 28474256 }}</ref><ref name=pmid28654427>{{Cite journal \| last1 = de Kock \| first1 = L. \| last2 = Terzic \| first2 = T. \| last3 = McCluggage \| first3 = WG. \| last4 = Stewart \| first4 = CJR. \| last5 = Shaw \| first5 = P. \| last6 = Foulkes \| first6 = WD. \| last7 = Clarke \| first7 = BA. \| title = DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. \| journal = Am J Surg Pathol \| volume = 41 \| issue = 9 \| pages = 1178-1187 \| month = Sep \| year = 2017 \| doi = 10.1097/PAS.0000000000000895 \| PMID = 28654427 }}</ref>
	*[[Cystic nephroma, pediatric type]].<ref name=pmid26772403>{{cite journal \|authors=Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ \|title=Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations \|journal=Hum Pathol \|volume=48 \|issue= \|pages=81–7 \|date=February 2016 \|pmid=26772403 \|pmc=4979561 \|doi=10.1016/j.humpath.2015.08.022 \|url=}}</ref>		*[[Cystic nephroma, pediatric type]].<ref name=pmid26772403>{{cite journal \|authors=Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ \|title=Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations \|journal=Hum Pathol \|volume=48 \|issue= \|pages=81–7 \|date=February 2016 \|pmid=26772403 \|pmc=4979561 \|doi=10.1016/j.humpath.2015.08.022 \|url=}}</ref><ref name=pmid28222777>{{cite journal \|authors=Fernández-Martínez L, Villegas JA, Santamaría Í, Pitiot AS, Alvarado MG, Fernández S, Torres H, Paredes Á, Blay P, Balbín M \|title=Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree \|journal=BMC Cancer \|volume=17 \|issue=1 \|pages=146 \|date=February 2017 \|pmid=28222777 \|pmc=5320664 \|doi=10.1186/s12885-017-3136-5 \|url=}}</ref>

	==References==		==References==

Michael at 15:41, 10 March 2022

2022-03-10T15:41:20Z

← Older revision		Revision as of 15:41, 10 March 2022
Line 5:		Line 5:
	*[[Pineoblastoma]].<ref name=pmid28960912/>		*[[Pineoblastoma]].<ref name=pmid28960912/>
	*Ovarian [[Sertoli-Leydig cell tumour]].<ref name=pmid28474256>{{Cite journal \| last1 = Bueno \| first1 = MT. \| last2 = Martínez-Ríos \| first2 = C. \| last3 = la Puente Gregorio \| first3 = A. \| last4 = Ahyad \| first4 = RA. \| last5 = Villani \| first5 = A. \| last6 = Druker \| first6 = H. \| last7 = van Engelen \| first7 = K. \| last8 = Gallinger \| first8 = B. \| last9 = Aronoff \| first9 = L. \| title = Pediatric imaging in DICER1 syndrome. \| journal = Pediatr Radiol \| volume = 47 \| issue = 10 \| pages = 1292-1301 \| month = Sep \| year = 2017 \| doi = 10.1007/s00247-017-3875-0 \| PMID = 28474256 }}</ref><ref name=pmid28654427>{{Cite journal \| last1 = de Kock \| first1 = L. \| last2 = Terzic \| first2 = T. \| last3 = McCluggage \| first3 = WG. \| last4 = Stewart \| first4 = CJR. \| last5 = Shaw \| first5 = P. \| last6 = Foulkes \| first6 = WD. \| last7 = Clarke \| first7 = BA. \| title = DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. \| journal = Am J Surg Pathol \| volume = 41 \| issue = 9 \| pages = 1178-1187 \| month = Sep \| year = 2017 \| doi = 10.1097/PAS.0000000000000895 \| PMID = 28654427 }}</ref>		*Ovarian [[Sertoli-Leydig cell tumour]].<ref name=pmid28474256>{{Cite journal \| last1 = Bueno \| first1 = MT. \| last2 = Martínez-Ríos \| first2 = C. \| last3 = la Puente Gregorio \| first3 = A. \| last4 = Ahyad \| first4 = RA. \| last5 = Villani \| first5 = A. \| last6 = Druker \| first6 = H. \| last7 = van Engelen \| first7 = K. \| last8 = Gallinger \| first8 = B. \| last9 = Aronoff \| first9 = L. \| title = Pediatric imaging in DICER1 syndrome. \| journal = Pediatr Radiol \| volume = 47 \| issue = 10 \| pages = 1292-1301 \| month = Sep \| year = 2017 \| doi = 10.1007/s00247-017-3875-0 \| PMID = 28474256 }}</ref><ref name=pmid28654427>{{Cite journal \| last1 = de Kock \| first1 = L. \| last2 = Terzic \| first2 = T. \| last3 = McCluggage \| first3 = WG. \| last4 = Stewart \| first4 = CJR. \| last5 = Shaw \| first5 = P. \| last6 = Foulkes \| first6 = WD. \| last7 = Clarke \| first7 = BA. \| title = DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. \| journal = Am J Surg Pathol \| volume = 41 \| issue = 9 \| pages = 1178-1187 \| month = Sep \| year = 2017 \| doi = 10.1097/PAS.0000000000000895 \| PMID = 28654427 }}</ref>
			*[[Cystic nephroma, pediatric type]].<ref name=pmid26772403>{{cite journal \|authors=Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ \|title=Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations \|journal=Hum Pathol \|volume=48 \|issue= \|pages=81–7 \|date=February 2016 \|pmid=26772403 \|pmc=4979561 \|doi=10.1016/j.humpath.2015.08.022 \|url=}}</ref>

	==References==		==References==

Michael: +another ref

2018-09-11T09:44:34Z

+another ref

← Older revision		Revision as of 09:44, 11 September 2018
Line 4:		Line 4:
	*[[Pleuropulmonary blastoma]] (PPB).<ref name=pmid28960912>{{Cite journal \| last1 = van Engelen \| first1 = K. \| last2 = Villani \| first2 = A. \| last3 = Wasserman \| first3 = JD. \| last4 = Aronoff \| first4 = L. \| last5 = Greer \| first5 = MC. \| last6 = Tijerin Bueno \| first6 = M. \| last7 = Gallinger \| first7 = B. \| last8 = Kim \| first8 = RH. \| last9 = Grant \| first9 = R. \| title = DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center. \| journal = Pediatr Blood Cancer \| volume = 65 \| issue = 1 \| pages = \| month = Jan \| year = 2018 \| doi = 10.1002/pbc.26720 \| PMID = 28960912 }}</ref>		*[[Pleuropulmonary blastoma]] (PPB).<ref name=pmid28960912>{{Cite journal \| last1 = van Engelen \| first1 = K. \| last2 = Villani \| first2 = A. \| last3 = Wasserman \| first3 = JD. \| last4 = Aronoff \| first4 = L. \| last5 = Greer \| first5 = MC. \| last6 = Tijerin Bueno \| first6 = M. \| last7 = Gallinger \| first7 = B. \| last8 = Kim \| first8 = RH. \| last9 = Grant \| first9 = R. \| title = DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center. \| journal = Pediatr Blood Cancer \| volume = 65 \| issue = 1 \| pages = \| month = Jan \| year = 2018 \| doi = 10.1002/pbc.26720 \| PMID = 28960912 }}</ref>
	*[[Pineoblastoma]].<ref name=pmid28960912/>		*[[Pineoblastoma]].<ref name=pmid28960912/>
	*Ovarian [[Sertoli-Leydig cell tumour]].<ref name=pmid28474256>{{Cite journal \| last1 = Bueno \| first1 = MT. \| last2 = Martínez-Ríos \| first2 = C. \| last3 = la Puente Gregorio \| first3 = A. \| last4 = Ahyad \| first4 = RA. \| last5 = Villani \| first5 = A. \| last6 = Druker \| first6 = H. \| last7 = van Engelen \| first7 = K. \| last8 = Gallinger \| first8 = B. \| last9 = Aronoff \| first9 = L. \| title = Pediatric imaging in DICER1 syndrome. \| journal = Pediatr Radiol \| volume = 47 \| issue = 10 \| pages = 1292-1301 \| month = Sep \| year = 2017 \| doi = 10.1007/s00247-017-3875-0 \| PMID = 28474256 }}</ref>		*Ovarian [[Sertoli-Leydig cell tumour]].<ref name=pmid28474256>{{Cite journal \| last1 = Bueno \| first1 = MT. \| last2 = Martínez-Ríos \| first2 = C. \| last3 = la Puente Gregorio \| first3 = A. \| last4 = Ahyad \| first4 = RA. \| last5 = Villani \| first5 = A. \| last6 = Druker \| first6 = H. \| last7 = van Engelen \| first7 = K. \| last8 = Gallinger \| first8 = B. \| last9 = Aronoff \| first9 = L. \| title = Pediatric imaging in DICER1 syndrome. \| journal = Pediatr Radiol \| volume = 47 \| issue = 10 \| pages = 1292-1301 \| month = Sep \| year = 2017 \| doi = 10.1007/s00247-017-3875-0 \| PMID = 28474256 }}</ref><ref name=pmid28654427>{{Cite journal \| last1 = de Kock \| first1 = L. \| last2 = Terzic \| first2 = T. \| last3 = McCluggage \| first3 = WG. \| last4 = Stewart \| first4 = CJR. \| last5 = Shaw \| first5 = P. \| last6 = Foulkes \| first6 = WD. \| last7 = Clarke \| first7 = BA. \| title = DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. \| journal = Am J Surg Pathol \| volume = 41 \| issue = 9 \| pages = 1178-1187 \| month = Sep \| year = 2017 \| doi = 10.1097/PAS.0000000000000895 \| PMID = 28654427 }}</ref>

	==References==		==References==

Michael at 20:27, 21 August 2018

2018-08-21T20:27:15Z

← Older revision		Revision as of 20:27, 21 August 2018
Line 4:		Line 4:
	*[[Pleuropulmonary blastoma]] (PPB).<ref name=pmid28960912>{{Cite journal \| last1 = van Engelen \| first1 = K. \| last2 = Villani \| first2 = A. \| last3 = Wasserman \| first3 = JD. \| last4 = Aronoff \| first4 = L. \| last5 = Greer \| first5 = MC. \| last6 = Tijerin Bueno \| first6 = M. \| last7 = Gallinger \| first7 = B. \| last8 = Kim \| first8 = RH. \| last9 = Grant \| first9 = R. \| title = DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center. \| journal = Pediatr Blood Cancer \| volume = 65 \| issue = 1 \| pages = \| month = Jan \| year = 2018 \| doi = 10.1002/pbc.26720 \| PMID = 28960912 }}</ref>		*[[Pleuropulmonary blastoma]] (PPB).<ref name=pmid28960912>{{Cite journal \| last1 = van Engelen \| first1 = K. \| last2 = Villani \| first2 = A. \| last3 = Wasserman \| first3 = JD. \| last4 = Aronoff \| first4 = L. \| last5 = Greer \| first5 = MC. \| last6 = Tijerin Bueno \| first6 = M. \| last7 = Gallinger \| first7 = B. \| last8 = Kim \| first8 = RH. \| last9 = Grant \| first9 = R. \| title = DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center. \| journal = Pediatr Blood Cancer \| volume = 65 \| issue = 1 \| pages = \| month = Jan \| year = 2018 \| doi = 10.1002/pbc.26720 \| PMID = 28960912 }}</ref>
	*[[Pineoblastoma]].<ref name=pmid28960912/>		*[[Pineoblastoma]].<ref name=pmid28960912/>
			*Ovarian [[Sertoli-Leydig cell tumour]].<ref name=pmid28474256>{{Cite journal \| last1 = Bueno \| first1 = MT. \| last2 = Martínez-Ríos \| first2 = C. \| last3 = la Puente Gregorio \| first3 = A. \| last4 = Ahyad \| first4 = RA. \| last5 = Villani \| first5 = A. \| last6 = Druker \| first6 = H. \| last7 = van Engelen \| first7 = K. \| last8 = Gallinger \| first8 = B. \| last9 = Aronoff \| first9 = L. \| title = Pediatric imaging in DICER1 syndrome. \| journal = Pediatr Radiol \| volume = 47 \| issue = 10 \| pages = 1292-1301 \| month = Sep \| year = 2017 \| doi = 10.1007/s00247-017-3875-0 \| PMID = 28474256 }}</ref>

	==References==		==References==

Michael at 20:25, 21 August 2018

2018-08-21T20:25:32Z

← Older revision		Revision as of 20:25, 21 August 2018
Line 1:		Line 1:
	'''DICER1 syndrome''' is characterized by mutations in the DICER1 gene.		'''DICER1 syndrome''' is characterized by mutations in the DICER1 gene.

	~~Tumour~~ associated with the syndrome include:		Conditions associated with the syndrome include:
	*[[Pleuropulmonary blastoma]] (PPB).<ref name=pmid28960912>{{Cite journal \| last1 = van Engelen \| first1 = K. \| last2 = Villani \| first2 = A. \| last3 = Wasserman \| first3 = JD. \| last4 = Aronoff \| first4 = L. \| last5 = Greer \| first5 = MC. \| last6 = Tijerin Bueno \| first6 = M. \| last7 = Gallinger \| first7 = B. \| last8 = Kim \| first8 = RH. \| last9 = Grant \| first9 = R. \| title = DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center. \| journal = Pediatr Blood Cancer \| volume = 65 \| issue = 1 \| pages = \| month = Jan \| year = 2018 \| doi = 10.1002/pbc.26720 \| PMID = 28960912 }}</ref>		*[[Pleuropulmonary blastoma]] (PPB).<ref name=pmid28960912>{{Cite journal \| last1 = van Engelen \| first1 = K. \| last2 = Villani \| first2 = A. \| last3 = Wasserman \| first3 = JD. \| last4 = Aronoff \| first4 = L. \| last5 = Greer \| first5 = MC. \| last6 = Tijerin Bueno \| first6 = M. \| last7 = Gallinger \| first7 = B. \| last8 = Kim \| first8 = RH. \| last9 = Grant \| first9 = R. \| title = DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center. \| journal = Pediatr Blood Cancer \| volume = 65 \| issue = 1 \| pages = \| month = Jan \| year = 2018 \| doi = 10.1002/pbc.26720 \| PMID = 28960912 }}</ref>
	*[[Pineoblastoma]].<ref name=pmid28960912/>		*[[Pineoblastoma]].<ref name=pmid28960912/>

Michael: create

2018-08-21T20:25:09Z

create

New page

'''DICER1 syndrome''' is characterized by mutations in the DICER1 gene.

Tumour associated with the syndrome include:
*[[Pleuropulmonary blastoma]] (PPB).<ref name=pmid28960912>{{Cite journal | last1 = van Engelen | first1 = K. | last2 = Villani | first2 = A. | last3 = Wasserman | first3 = JD. | last4 = Aronoff | first4 = L. | last5 = Greer | first5 = MC. | last6 = Tijerin Bueno | first6 = M. | last7 = Gallinger | first7 = B. | last8 = Kim | first8 = RH. | last9 = Grant | first9 = R. | title = DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care center. | journal = Pediatr Blood Cancer | volume = 65 | issue = 1 | pages = | month = Jan | year = 2018 | doi = 10.1002/pbc.26720 | PMID = 28960912 }}</ref>
*[[Pineoblastoma]].<ref name=pmid28960912/>

==References==
{{Reflist|1}}

[[Category:Syndromes]]